Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mauricio A. Arias
Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization With HIVgp140
PLoS ONE
Multidisciplinary
Related publications
The TLR4 Agonist Adjuvant SLA-SE Promotes Functional Mucosal Antibodies Against a Parenterally Delivered ETEC Vaccine
npj Vaccines
Infectious Diseases
Immunology
Pharmacology
Bacillus thuringiensisCry1Ac Protoxin Is a Potent Systemic and Mucosal Adjuvant
Scandinavian Journal of Immunology
Medicine
Immunology
Improved Systemic and Mucosal Antibody Responses With a CCR10 Ligand Adjuvant
Retrovirology
Virology
Infectious Diseases
Schistosoma Mansoni Antigen Sm-P80: Prophylactic Efficacy Using TLR4 Agonist Vaccine Adjuvant Glucopyranosyl Lipid A-Alum in Murine and Non-Human Primate Models
Journal of Investigative Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Intranasal Immunization With Mumps Virus DNA Vaccine Delivered by Influenza Virosomes Elicits Mucosal and Systemic Immunity
Virology
Virology
Transcutaneous Immunization With Phosphorylcholine Induces Antigen-Specific Mucosal and Systemic Immune Responses in BALB/c Mice
Journal of Otolaryngology of Japan
Otorhinolaryngology
TLR4 Agonist GLA Modifies Th1/Th2 Cytokine Profiles in PBMC From Patients With Pollen Allergy
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Intranasal Immunization With a Formalin-Inactivated Human Influenza a Virus Whole-Virion Vaccine Alone and Intranasal Immunization With a Split-Virion Vaccine With Mucosal Adjuvants Show Similar Levels of Cross-Protection
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Polyethyleneimine Is a Potent Mucosal Adjuvant for Viral Glycoprotein Antigens
Nature Biotechnology
Applied Microbiology
Biotechnology
Biomedical Engineering
Molecular Medicine
Bioengineering
